NCT01980459View on ClinicalTrials.gov

Magnesium Treatment of Inflammation in Disorders of Glucose Homeostasis

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Non-Insulin Dependent Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

magnesium lactate

Patient will be given 4 tablets a day of study supplement (Magnesium Lactate) for 3 months. Magnesium cellular and serum levels will be compared prior and post intervention.

Trial Locations (1)

Unknown

The Dasman Diabetes Institute, Kuwait City

All Listed Sponsors
collaborator

Nadia Zghoul, PhD, Dept of Clinical Research

UNKNOWN

collaborator

Dasman Diabetes Institute

OTHER

lead

George Washington University

OTHER

NCT01980459 - Magnesium Treatment of Inflammation in Disorders of Glucose Homeostasis | Biotech Hunter | Biotech Hunter